Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merrill D Benson

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Blood|July 28, 2009
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantationArie J Stangou, Nicholas R Banner, Bruce M Hendry, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 1, 2012
Solid organ transplantation for non-TTR hereditary amyloidosis: report from the 1st International Workshop on the Hereditary Renal AmyloidosesArie J Stangou, Luisa Lobato, Steven Zeldenrust, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 30, 2013
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosisElisabet Ihse, Claudio Rapezzi, Giampaolo Merlini, et al.
The Journal of Biological Chemistry|June 7, 2019
A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pHMitsuharu Ueda, Masamitsu Okada, Mineyuki Mizuguchi, et al.
ESC Heart Failure|December 7, 2020
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 dataNicholas J Viney, Shuling Guo, Li-Jung Tai, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2018
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trialMarcia Waddington-Cruz, Elizabeth J Ackermann, Michael Polydefkis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 20, 2007
Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosisBouke P C Hazenberg, Johan Bijzet, Pieter C Limburg, et al.
Journal of Neurology|July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateThomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Journal of Neurology|December 20, 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosisTeresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Blood|July 28, 2009
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantationArie J Stangou, Nicholas R Banner, Bruce M Hendry, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 1, 2012
Solid organ transplantation for non-TTR hereditary amyloidosis: report from the 1st International Workshop on the Hereditary Renal AmyloidosesArie J Stangou, Luisa Lobato, Steven Zeldenrust, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 30, 2013
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosisElisabet Ihse, Claudio Rapezzi, Giampaolo Merlini, et al.
The Journal of Biological Chemistry|June 7, 2019
A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pHMitsuharu Ueda, Masamitsu Okada, Mineyuki Mizuguchi, et al.
ESC Heart Failure|December 7, 2020
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 dataNicholas J Viney, Shuling Guo, Li-Jung Tai, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2018
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trialMarcia Waddington-Cruz, Elizabeth J Ackermann, Michael Polydefkis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 20, 2007
Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosisBouke P C Hazenberg, Johan Bijzet, Pieter C Limburg, et al.
Journal of Neurology|July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateThomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Journal of Neurology|December 20, 2019
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosisTeresa Coelho, Aaron Yarlas, Marcia Waddington-Cruz, et al.
Pageof 10